NO
EW icon

Ninety One’s Edwards Lifesciences EW Stock Holding History

Ninety One’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.8M Buy
262,942
+7,033
+3% +$589K 1.29% 9
2026
Q1 		$20.2M Buy
255,909
+74,403
+41% +$6.13M 0.87% 13
2025
Q4 		$15.5M Buy
181,506
+4,072
+2% +$334K 0.67% 23
2025
Q3 		$13.8M Buy
177,434
+37,656
+27% +$2.94M 0.62% 27
2025
Q2 		$10.9M Sell
139,778
-5,206
-4% -$388K 1.79% 17
2025
Q1 		$10.5M Buy
144,984
+91,888
+173% +$6.58M 1.94% 16
2024
Q4 		$3.93M Sell
53,096
-22,422
-30% -$1.57M 0.87% 30
2024
Q3 		$4.98M Buy
75,518
+3,695
+5% +$268K 1.09% 27
2024
Q2 		$6.66M Sell
71,823
-10,357
-13% -$917K 1.03% 31
2024
Q1 		$7.84M Buy
82,180
+73,187
+814% +$6.15M 1.13% 30
2023
Q4 		$686K Buy
+8,993
New +$626K 0.1% 58

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Ninety One's EW Position: Q2 2026 in Review

Ninety One increased its Edwards Lifesciences (EW) stake by 2.7% in Q2 2026, buying an estimated $589K and bringing the position to 262,942 shares worth $23.8M. The position accounts for 1.29% of the portfolio, ranked #9.

Ninety One first reported a position in EW in Q4 2023 and has held it in 11 quarters since. 1,330 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Ninety One held 262,942 shares of Edwards Lifesciences worth $23.8M as of Q2 2026.
  • Ninety One bought 7,033 Edwards Lifesciences shares in Q2 2026, an estimated $589K.
  • Edwards Lifesciences made up 1.29% of Ninety One's portfolio in Q2 2026, its #9 holding.
  • Ninety One first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • 1,330 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Ninety One's 13F filing for Q2 2026, filed 16 Jul 2026.